Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Vaccine

• Publication date

  2013-12-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2013.10.033PMID 24144473
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial

  2013cited by this paper
• Middleton's Allergy: Principles and Practice

  2013cited by this paper
• Bell's Palsy Cases Following Administration of Influenza A (H1N1) 2009 Monovalent Vaccine Reported to the Vaccine Adverse Event Reporting System (VAERS)

  2012cited by this paper
• Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China.

  2011cited by this paper
• Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance.

  2011cited by this paper
• Spontaneous reporting of adverse events following immunisation against pandemic influenza in Denmark November 2009-March 2010.

  2011cited by this paper
• Anaphylaxis following H1N1 pandemic vaccines: safety data in perspective.

  2011cited by this paper
• Monitoring adverse events of the vaccination campaign against influenza A (H1N1) in the Netherlands.

  2010cited by this paper
• Diagnostic Utility of Two Case Definitions for Anaphylaxis

  2010cited by this paper
• Annual report: surveillance of adverse events following immunisation in Australia, 2004.

  2010cited by this paper
• Annual report: surveillance of adverse events following immunisation in Australia, 2009.

  2010cited by this paper
• Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.

  2010cited by this paper
• Analysis of food-allergic and anaphylactic events in the National Electronic Injury Surveillance System.

  2008cited by this paper
• Gender difference, sex hormones, and immediate type hypersensitivity reactions

  2008cited by this paper
• Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.

  2007cited by this paper
• Anaphylaxis as an adverse event following immunisation

  2006cited by this paper
• Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group.

  2006cited by this paper
• Use of epinephrine in the treatment of anaphylaxis

  2003cited by this paper
• Risk of anaphylaxis after vaccination of children and adolescents.

  2003cited by this paper
• Type 1/Type 2 immunity in infectious diseases.

  2001cited by this paper
• Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up.

  2000cited by this paper
• Anaphylactic Shock after Insect-Sting Challenge in 138 Persons with a Previous Insect-Sting Reaction

  1993cited by this paper
• Gouvernement du Québec.

  1971cited by this paper

• New-onset anesthesia/paresthesia following the administration of COVID-19 vaccines in Quebec, Canada.

  2025cites this paper
• Subunit antigen delivery: emulsion and liposomal adjuvants for next-generation vaccines

  2025cites this paper
• An Adjuvanted Vaccine-Induced Pathogenesis Following Influenza Virus Infection

  2024cites this paper
• Adverse Events Following Vaccines: From Detection to Research Translation.

  2024cites this paper
• The potential of nano- and microparticle-based influenza vaccines with enhanced shelf lives.

  2024cites this paper
• Assessment of Potential Adverse Events Following the 2022 to 2023 Seasonal Influenza Vaccines Among U.S. Adults Aged 65 Years and Older

  2023cites this paper
• Global burden of vaccine‐associated anaphylaxis and their related vaccines, 1967–2023: A comprehensive analysis of the international pharmacovigilance database

  2023cites this paper
• Identifying and managing those at risk for vaccine related allergy and anaphylaxis.

  2023cites this paper
• Vaccine confidence among those living with allergy during the COVID pandemic (ACCORD): A scoping review

  2023cites this paper
• [Anaphylaxis caused by vaccines].

  2022cites this paper
• Immediate Hypersensitivity Reactions Induced by COVID-19 Vaccines: Current Trends, Potential Mechanisms and Prevention Strategies

  2022cites this paper
• Delivery strategies for cancer vaccines and immunoadjuvants

  2022cites this paper
• Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives

  2021cites this paper
• Evaluation of Adverse Reactions to Vaccines.

  2021cites this paper
• Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health-care system experience.

  2021cites this paper
• Revaccination following suspected vaccine-triggered hypersensitivity reactions: experience of a tertiary care centre.

  2021cites this paper
• Diagnosis and management of hypersensitivity reactions to vaccines

  2020cites this paper
• Considerations for Size, Surface Charge, Polymer Degradation, Co‐Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious Diseases

  2020cites this paper
• Safety of AS03-adjuvanted influenza vaccines: A review of the evidence.

  2019cites this paper
• Influenza A(H5N1) Virus Subunit Vaccine Administered with CaPNP Adjuvant Induce High Virus Neutralization Antibody Titers in Mice

  2019cites this paper
• The Epidemiology of Anaphylaxis

  2018cites this paper
• A CASE STUDY : THE SCHOOL EXPERIENCES OF CHILDREN WITH LIFE-THREATENING FOOD-INDUCED ALLERGIES AND ANAPHYLAXIS AS PERCEIVED BY CHILDREN, PARENTS, TEACHERS, AND A SCHOOL ADMINISTRATOR

  2017cites this paper
• Advancing new vaccines against pandemic influenza in low-resource countries.

  2017cites this paper
• Background Document for “Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2017-18 Influenza Season” Introduction

  2017cites this paper
• Universal influenza vaccines: Shifting to better vaccines

  2016cites this paper
• Risk of anaphylaxis after vaccination in children and adults.

  2016cites this paper
• Anaphylaxis After Immunization of Children and Adolescents in Germany

  2016cites this paper
• International Consensus (ICON): allergic reactions to vaccines

  2016cites this paper
• Paresthesia and sensory disturbances associated with 2009 pandemic vaccine receipt: Clinical features and risk factors.

  2015cites this paper
• Ryzyko anafilaksji po szczepieniach ochronnych u dzieci i dorosłych

  2015cites this paper
• The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper.

  2015cites this paper
• Seasonal split influenza vaccine induced IgE sensitization against influenza vaccine.

  2015cites this paper
• The basics and advances of immunomodulators and antigen presentation: a key to development of potent memory response against pathogens

  2014cites this paper
• A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010.

  2014cites this paper
• Risk factors associated with anaphylaxis and other allergic-like events following receipt of 2009 monovalent AS03-adjuvanted pandemic influenza vaccine in Quebec, Canada.

  2014cites this paper
• Clinical reviews in allergy and immunology Vaccine-associated hypersensitivity

  year unknowncites this paper